GROUP ONE TRADING, L.P. - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is and the CUSIP is 98986X909. A total of 3 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$44,958
+3840.2%
35,400
+911.4%
0.00%
Q2 2023$1,141
-26.3%
3,500
-2.8%
0.00%
Q1 2023$1,548
-42.7%
3,600
-29.4%
0.00%
Q4 2022$2,703
-32.4%
5,100
-1.9%
0.00%
Q3 2022$4,000
-63.6%
5,200
-47.5%
0.00%
Q2 2022$11,000
-69.4%
9,900
-44.1%
0.00%
Q1 2022$36,000
-85.5%
17,700
-79.4%
0.00%
Q4 2021$248,000
-46.8%
86,100
-21.7%
0.00%
-100.0%
Q3 2021$466,000
-54.9%
110,000
-43.7%
0.00%0.0%
Q2 2021$1,034,000
+3.3%
195,400
-9.2%
0.00%0.0%
Q1 2021$1,001,000
+163.4%
215,300
+86.7%
0.00%0.0%
Q4 2020$380,000
-9.1%
115,300
-8.6%
0.00%0.0%
Q3 2020$418,000
-74.4%
126,200
-74.0%
0.00%
-87.5%
Q2 2020$1,633,000
+463.1%
484,500
+540.9%
0.01%
+300.0%
Q1 2020$290,000
-63.4%
75,600
-42.4%
0.00%
-60.0%
Q4 2019$793,000
+17.1%
131,300
+46.5%
0.01%0.0%
Q3 2019$677,000
+24.7%
89,600
+123.4%
0.01%0.0%
Q2 2019$543,000
+182.8%
40,100
+13.3%
0.01%
+150.0%
Q1 2019$192,000
+68.4%
35,400
-7.8%
0.00%
+100.0%
Q4 2018$114,000
-63.3%
38,400
+0.8%
0.00%
-50.0%
Q3 2018$311,000
-26.7%
38,100
-12.4%
0.00%
-50.0%
Q2 2018$424,000
+91.0%
43,500
+69.9%
0.00%
+100.0%
Q1 2018$222,000
-76.6%
25,600
-66.1%
0.00%
-71.4%
Q4 2017$947,000
-43.5%
75,600
-62.3%
0.01%
-53.3%
Q3 2017$1,676,000
+41.7%
200,500
+187.7%
0.02%
+25.0%
Q2 2017$1,183,000
-45.4%
69,700
-35.3%
0.01%
-52.0%
Q1 2017$2,167,000
+98.8%
107,800
+54.2%
0.02%
+127.3%
Q4 2016$1,090,000
+890.9%
69,900
+732.1%
0.01%
+1000.0%
Q3 2016$110,0008,4000.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
SIMPLEX TRADING, LLC 7,500$30.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 3,600$1,5480.00%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders